LXRX - Lexicon Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue90,33583,337130,014
Cost of Revenue1,899--
Gross Profit88,43683,337130,014
Operating Expenses
Research Development156,813178,15195,187
Selling General and Administrative68,30442,34129,762
Non Recurring--3,597
Total Operating Expenses---
Operating Income or Loss-136,681-137,1551,468
Income from Continuing Operations
Total Other Income/Expenses Net1,9542,293572
Earnings Before Interest and Taxes-134,727-134,8622,040
Interest Expense6,9846,5676,722
Income Before Tax-141,711-141,429-4,682
Income Tax Expense-12,661--
Minority Interest---
Net Income From Continuing Ops-129,050-141,429-4,682
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-129,050-141,429-4,682
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-129,050-141,429-4,682